Moritz H Albrecht1,2, Matthew W Bickford1, John W Nance1, Longjiang Zhang3, Carlo N De Cecco1, Julian L Wichmann2, Thomas J Vogl2, U Joseph Schoepf1,3. 1. 1 Department of Radiology and Radiological Science, Division of Cardiovascular Imaging, Medical University of South Carolina, 25 Courtenay Dr, Ashley River Tower, Charleston, SC 29425. 2. 2 Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany. 3. 3 Department of Medical Imaging, Jinling Hospital, Medical School of Nanjing University, Jiangsu, China.
Abstract
OBJECTIVE: Pulmonary CT angiography (CTA) is the imaging modality of choice in suspected acute pulmonary embolism (PE). Current pulmonary CTA techniques involve ever lower doses of contrast medium and radiation along with advanced postprocessing applications to enhance image quality, diagnostic accuracy, and provide added value in patient management. The objective of this article is to summarize these current developments and discuss the appropriate use of state-of-the-art pulmonary CTA. CONCLUSION: Pulmonary CTA is well established as a fast and reliable means of excluding or diagnosing PE. Continued developments in CT system hardware and postprocessing techniques will allow incremental reductions in radiation and contrast material requirements while improving image quality. Advances in risk stratification and prognostication from pulmonary CTA examinations should further refine its clinical value while minimizing the potential harm from overutilization and overdiagnosis.
OBJECTIVE: Pulmonary CT angiography (CTA) is the imaging modality of choice in suspected acute pulmonary embolism (PE). Current pulmonary CTA techniques involve ever lower doses of contrast medium and radiation along with advanced postprocessing applications to enhance image quality, diagnostic accuracy, and provide added value in patient management. The objective of this article is to summarize these current developments and discuss the appropriate use of state-of-the-art pulmonary CTA. CONCLUSION: Pulmonary CTA is well established as a fast and reliable means of excluding or diagnosing PE. Continued developments in CT system hardware and postprocessing techniques will allow incremental reductions in radiation and contrast material requirements while improving image quality. Advances in risk stratification and prognostication from pulmonary CTA examinations should further refine its clinical value while minimizing the potential harm from overutilization and overdiagnosis.
Authors: Tommaso D'Angelo; Giuseppe Cicero; Silvio Mazziotti; Giorgio Ascenti; Moritz H Albrecht; Simon S Martin; Ahmed E Othman; Thomas J Vogl; Julian L Wichmann Journal: Br J Radiol Date: 2019-04-09 Impact factor: 3.039
Authors: Simone Cristina Soares Brandão; Júlia de Oliveira Xavier Ramos; Gustavo Freitas Alves de Arruda; Emmanuelle Tenório Albuquerque Madruga Godoi; Lara Cristiane Terra Ferreira Carreira; Rafael Willain Lopes; Gabriel Blacher Grossman; Ronaldo de Souza Leão Lima Journal: Am J Nucl Med Mol Imaging Date: 2020-12-15
Authors: Mazen S Albaghdadi; David M Dudzinski; Nicholas Giordano; Christopher Kabrhel; Brian Ghoshhajra; Michael R Jaff; Ido Weinberg; Aaron Baggish Journal: J Am Heart Assoc Date: 2018-03-03 Impact factor: 5.501
Authors: Sayan Manna; Jill Wruble; Samuel Z Maron; Danielle Toussie; Nicholas Voutsinas; Mark Finkelstein; Mario A Cedillo; Jamie Diamond; Corey Eber; Adam Jacobi; Michael Chung; Adam Bernheim Journal: Radiol Cardiothorac Imaging Date: 2020-06-01
Authors: Imon Banerjee; Miji Sofela; Jaden Yang; Jonathan H Chen; Nigam H Shah; Robyn Ball; Alvin I Mushlin; Manisha Desai; Joseph Bledsoe; Timothy Amrhein; Daniel L Rubin; Roham Zamanian; Matthew P Lungren Journal: JAMA Netw Open Date: 2019-08-02